1. Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. (September 2017) Authors: Schadendorf, Dirk; Long, Georgina V.; Stroiakovski, Daniil; Karaszewska, Boguslawa; Hauschild, Axel; Levchenko, Evgeny; Chiarion-Sileni, Vanna; Schachter, Jacob; Garbe, Claus; Dutriaux, Caroline; Gogas, Helen; Mandalà, Mario; Haanen, John B.A.G.; Lebbé, Céleste; Mackiewicz, Andrzej; Rutkowski, Pi... Journal: European journal of cancer Issue: Volume 82(2017) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗